Currently out of the existing stock ratings of Ryan Langston, 65 are a BUY (61.32%), 41 are a HOLD (38.68%).

Ryan Langston

Work Performance Price Targets & Ratings Chart

Analyst Ryan Langston, currently employed at TD COWEN, carries an average stock price target met ratio of 60.55% that have a potential upside of 16.77% achieved within 89 days.

Ryan Langston’s has documented 210 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HCA, HCA Holdings.

Wall Street Analyst Ryan Langston

Analyst best performing recommendations are on MOH (MOLINA HEALTHCARE).
The best stock recommendation documented was for EHAB (ENHABIT) at 3/11/2024. The price target of $11 was fulfilled within 4 days with a profit of $1.11 (11.22%) receiving and performance score of 28.06.

Average potential price target upside

ACHC Acadia Healthcare Company ADUS Addus HomeCare AGL agilon health ASTH Astrana Health CNC Centene Corp DVA DaVita HealthCare Partners EHAB Enhabit ELV Elevance Health HCA HCA Holdings HUM Humana PRVA Privia Health Group SGRY Surgery Partners UHS Universal Health Services UNH UnitedHealth Group EHC Encompass Health Corp MOH Molina Healthcare PIII P3 Health Partners THC Tenet Healthcare

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 23-Sep-2026

$33

$1.49 (4.73%)

1 months 7 days ago
(23-Sep-2026)

8/14 (57.14%)

$4.49 (15.75%)

404

Hold Since 14-May-2025

$32

$0.49 (1.56%)

$25

3 months ago
(30-Jul-2026)

8/20 (40%)

$3.86 (13.72%)

127

Buy Since 09-Apr-2025

$39

$7.49 (23.77%)

$38

3 months ago
(30-Jul-2026)

4/7 (57.14%)

$10.86 (38.59%)

135

Buy Since 07-Jan-2025

$36

$4.49 (14.25%)

$30

3 months 16 days ago
(14-Jul-2026)

4/8 (50%)

$4.4 (13.92%)

42

Buy Since 05-Feb-2025

$40

$8.49 (26.94%)

$30

3 months 16 days ago
(14-Jul-2026)

7/12 (58.33%)

$8.4 (26.58%)

186

Show more analysts

Please expand the browser size to see the chart

Which stock is Ryan Langston most bullish on?

Potential upside of $63.68 has been obtained for ELV (ELEVANCE HEALTH)

Which stock is Ryan Langston most reserved on?

Potential downside of -$52.07 has been obtained for HUM (HUMANA)

What Year was the first public recommendation made by Ryan Langston?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?